Production (Stage)
Inspire Medical Systems, Inc.
INSP
$143.21
-$2.74-1.88%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 201.32M | 239.72M | 203.19M | 195.89M | 164.01M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 201.32M | 239.72M | 203.19M | 195.89M | 164.01M |
| Cost of Revenue | 30.71M | 35.99M | 32.40M | 29.84M | 24.76M |
| Gross Profit | 170.61M | 203.73M | 170.79M | 166.04M | 139.25M |
| SG&A Expenses | 144.29M | 141.51M | 130.39M | 132.08M | 125.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 202.80M | 207.83M | 188.87M | 190.79M | 179.23M |
| Operating Income | -1.49M | 31.88M | 14.32M | 5.10M | -15.22M |
| Income Before Tax | 4.16M | 36.64M | 20.33M | 10.85M | -9.36M |
| Income Tax Expenses | 1.17M | 1.41M | 1.83M | 1.05M | 650.00K |
| Earnings from Continuing Operations | 2.99M | 35.22M | 18.50M | 9.79M | -10.01M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.99M | 35.22M | 18.50M | 9.79M | -10.01M |
| EBIT | -1.49M | 31.88M | 14.32M | 5.10M | -15.22M |
| EBITDA | 1.56M | 34.36M | 16.17M | 6.48M | -14.38M |
| EPS Basic | 0.10 | 1.18 | 0.62 | 0.33 | -0.34 |
| Normalized Basic EPS | 0.09 | 0.77 | 0.43 | 0.23 | -0.20 |
| EPS Diluted | 0.10 | 1.14 | 0.60 | 0.32 | -0.34 |
| Normalized Diluted EPS | 0.09 | 0.74 | 0.41 | 0.22 | -0.20 |
| Average Basic Shares Outstanding | 29.70M | 29.83M | 29.88M | 29.73M | 29.62M |
| Average Diluted Shares Outstanding | 30.31M | 30.75M | 30.63M | 30.41M | 29.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |